Infant-onset Eczema in Relation to Mental Health Problems at Age 10 Years: Results from a Prospective Birth Cohort Study (German Infant Nutrition Intervention Plus)
Overview
Authors
Affiliations
Background: Cross-sectional studies suggest an association between eczema and mental health problems, but the temporal relationship is unclear.
Objective: To assess the association between infant-onset eczema and mental health problems in a prospective study.
Methods: Between 1995 and 1998, a birth cohort study was recruited and followed until age 10 years. Physician-diagnosed eczema, comorbidities, and a broad set of environmental exposures were assessed at age 1, 2, 3, 4, 6, and 10 years. First, we investigated the association between infant-onset eczema (age 1-2 years) and mental health problems at age 10 years according to the Strengths and Difficulties Questionnaire. Second, we analyzed the likelihood of mental health problems at age 10 years in relation to the course of eczema.
Results: A total of 2916 infants were eligible for analysis. Compared with participants never diagnosed as having eczema, children with infant-onset eczema had a significantly increased risk for possible/probable mental health problems (Strengths and Difficulties Questionnaire total score) at age 10 years (odds ratio, 1.49; 95% CI, 1.13-1.96) and for emotional symptoms (odds ratio, 1.62; 95% CI, 1.25-2.09). Eczema limited to infancy predicted a significantly higher risk for conduct problems at age 10 years. The strength of the association between eczema and emotional problems at age 10 years increased with increasing eczema persistence.
Conclusion: Infants with eczema are at increased risk for mental health problems at age 10 years. Even if cleared afterward, eczema at age 1 to 2 years may cause persistent emotional and behavioral difficulties.
Full Breastfeeding and Allergic Diseases-Long-Term Protection or Rebound Effects?.
Libuda L, Filipiak-Pittroff B, Standl M, Schikowski T, von Berg A, Koletzko S Nutrients. 2023; 15(12).
PMID: 37375684 PMC: 10301269. DOI: 10.3390/nu15122780.
Wan J, Shin D, Syed M, Abuabara K, Lemeshow A, Gelfand J J Eur Acad Dermatol Venereol. 2022; 37(1):114-122.
PMID: 36018560 PMC: 9929490. DOI: 10.1111/jdv.18564.
The link between atopic dermatitis and asthma- immunological imbalance and beyond.
Yaneva M, Darlenski R Asthma Res Pract. 2021; 7(1):16.
PMID: 34911576 PMC: 8672460. DOI: 10.1186/s40733-021-00082-0.
Atopic Eczema: Pathophysiological Findings as the Beginning of a New Era of Therapeutic Options.
Traidl S, Werfel T, Traidl-Hoffmann C Handb Exp Pharmacol. 2021; 268:101-115.
PMID: 34236520 DOI: 10.1007/164_2021_492.
Childhood atopic dermatitis as a precursor for developing attention deficit/hyperactivity disorder.
Xu Y, Wang J, Zhu W, Li P Int J Immunopathol Pharmacol. 2020; 34:2058738420962902.
PMID: 33045857 PMC: 7557683. DOI: 10.1177/2058738420962902.